Clinical trial
A Trial to Evaluate Placebo Microneedle Arrays in Healthy Human Volunteers (Part I), Followed by Proof of Concept Testing of Efficacy and Safety of Doxorubicin Microneedle Arrays in Subjects With Basal Cell Cancer (Part II)
NCT04928222 is registered in ClinicalTrials.gov with SkinJect, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial to Evaluate Placebo Microneedle Arrays in Healthy Human Volunteers (Part I), Followed by Proof of Concept Testing of Efficacy and Safety of Doxorubicin Microneedle Arrays in Subjects With Basal Cell Cancer (Part II)
- Lead sponsor
- SkinJect, Inc.
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- September 24, 2021
- Completion date
- June 30, 2024
- Enrollment
- 25 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.